Cerebral small vessel disease (SVD) is a major cause of age-related cognitive impairment and dementia. The pathophysiology of SVD is not well understood and is hampered by a limited range of relevant animal models. Here, we describe gliovascular alterations and cognitive deficits in a mouse model of sustained cerebral hypoperfusion with features of SVD (microinfarcts, hemorrhage, white matter disruption) induced by bilateral common carotid stenosis. Multiple features of SVD were determined on T2-weighted and diffusion-tensor magnetic resonance imaging scans and confirmed by pathologic assessment. These features, which were absent in sham controls, included multiple T2-hyperintense infarcts and T2-hypointense hemosiderin-like regions in subcortical nuclei plus increased cerebral atrophy compared with controls. Fractional anisotropy was also significantly reduced in several white matter structures including the corpus callosum. Investigation of gliovascular changes revealed a marked increase in microvessel diameter, vascular wall disruption, fibrinoid necrosis, hemorrhage, and blood-brain barrier alterations. Widespread reactive gliosis, including displacement of the astrocytic water channel, aquaporin 4, was observed. Hypoperfused mice also demonstrated deficits in spatial working and reference memory tasks. Overall, gliovascular disruption is a prominent feature of this mouse, which could provide a useful model for early-phase testing of potential SVD treatment strategies. Keywords: cognition; diffusion-tensor imaging; hypoperfusion; magnetic resonance imaging; small vessel disease INTRODUCTION Cerebral small vessel disease (SVD) is a major cause of age-related cognitive decline and dementia.
Journal of Cerebral Blood1 Hypertension is proposed to be a common risk factor (although it explains only a small proportion of imaging-determined SVD) and cerebral amyloid angiopathy is commonly present on pathologic examination.2,3 Clinically, SVD is associated with early impairment of attention and executive function with slowing of information processing and motor deficits.1 These clinical manifestations result primarily from the occurrence of lesions in the cerebral white matter, multiple lacunes within subcortical structures, atrophy, and, in some cases, microbleeds in deep gray matter, white matter, or at the corticosubcortical junction, identified by neuroimaging.2,4 White matter lesions, associated with increased extracellular fluid, varying degrees of myelin and axonal pathology, and glial responses, are predominantly detected as hyperintense regions on fluid attenuation inversion recovery and T2-weighted magnetic resonance imaging (MRI).5 Lacunes, which present as hypointense regions on fluid attenuation inversion recovery or T1-weighted MRI or hyperintense on T2-weighted MRI, are small deep cavities